Outlook: The Neuroscience Issue
Already one of the world’s premier institutions in neuroscience research, WashU Medicine is deepening its investment. Read about our approach, areas of focus and latest advances in Outlook Winter 2023-24.
Needleman innovation program seeks proposals for therapeutic development (Links to an external site)
Up to $4 million in funding available to pursue ‘investigational new drug’ status
Discovery suggests route to safer pain medications (Links to an external site)
Targeting opioid receptor pathway could treat pain without addiction, hallucinations
Stress increases Alzheimer’s risk in female mice but not males (Links to an external site)
Alzheimer’s proteins rise sharply in response to stress in female mice
Hultgren, Solnica-Krezel named to American Academy of Arts & Sciences (Links to an external site)
Recognized for gathering, applying knowledge in service of the public good
Woodard named head of Department of Radiology (Links to an external site)
Cardiothoracic imaging expert brings strengths in research, education, leadership
Drug for rare form of ALS, based in part on WashU research, approved by FDA (Links to an external site)
Washington University neurologist led international trials of the drug, tofersen
Sleeping pill reduces levels of Alzheimer’s proteins (Links to an external site)
More research needed to determine if sleep medications prevent, delay Alzheimer’s
Mind-body connection is built into brain, study suggests (Links to an external site)
Findings point to brain areas that integrate planning, purpose, physiology, behavior, movement
Bateman to receive lifetime achievement award (Links to an external site)
Recognized for contributions to Alzheimer’s disease research
An, Elson named 2023 AIMBE fellows (Links to an external site)
Recognized for research, innovation in medical and biological engineering